Preview

Современная ревматология

Расширенный поиск

Микотические инфекции в ревматологии

https://doi.org/10.14412/1996-7012-2017-2-18-24

Полный текст:

Аннотация

Проблема инвазивных микозов становится все более актуальной в современной ревматологии. Отмечаются сложности прижизненной диагностики и трудности терапии микозов у больных с ревматическими заболеваниями. Значимость данного вопроса существенно повышается в связи с активным внедрением в клиническую практику генно-инженерных биологических препаратов. В статье представлены основные данные о клинике, диагностике и терапии наиболее часто встречающихся микозов.

 

Об авторах

Б. С. Белов
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва
Россия


Г. М. Тарасова
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва
Россия


Д. В. Буханова
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва
Россия


Литература

1. Schmiedel Y, Zimmerli S. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly. 2016;146:w14281. doi: 10.4414/smw.2016.14281

2. Gregg KS, Kauffman CA. Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment. Semin Respir Crit Care Med. 2015;36(5):662-72. doi: 10.1055/s-0035- 1562893.

3. Wang LR, Barber CE, Johnson AS, Barnabe C. Invasive fungal disease in systemic lupus erythematosus: A systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum. 2014; 44(3):325-330. doi: 10.1016/j.semarthrit. 2014.06.001.

4. Ishiguro T, Takayanagi N, Takaku Y, et al. Combined Allergic Bronchopulmonary Aspergillosis and Eosinophilic Granulomatosis with Polyangiitis: Three Cases and a Review of the Literature. Intern Med. 2016;55(7):793-7. doi: 10.2169/internalmedicine.55.5431

5. Vallabhaneni S, Chiller TM. Fungal Infections and New Biologic Therapies. Curr Rheumatol Rep. 2016;18(5):29. doi: 10.1007/ s11926-016-0572-1

6. McCarty TP, Pappas PG. Invasive Candidiasis. Infect Dis Clin North Am. 2016;30(1):103-24. doi: 10.1016/j. idc.2015.10.013

7. Pеrez-Sola MJ, Torre-Cisneros J, Pеrez-Zafrilla B et al. Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry. Med Clint (Barc). 2011;137(12):533-40. doi: 10.1016/j. medcli.2010.11.032.

8. Saunte DM, Mrowietz U, Puig L, Zachariae C. Candida infections in psoriasis and psoriatic arthritis patients treated with IL-17 inhibitors and their practical management. Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15015. [Epub ahead of print].

9. Tattevin P, Revest M, Lefort A, et al. Fungal endocarditis: current challenges. Int J Antimicrob Agents. 2014;44(4):290-4. doi: 10.1016/j.ijantimicag.2014.07.003

10. Веселов АВ, Козлов РС. Инвазивный кандидоз: современные аспекты эпидемиологии, диагностики, терапии и профилактики у различных категорий пациентов (в вопросах и ответах). Клиническая микробиология и антимикробная химиотерапия. 2016;18 (Прил 2):1-103. [Veselov AV, Kozlov RS. Invasive candidiasis: modern aspects of epidemiology, diagnosis, therapy and prevention in different categories of patients (questions and answers). Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. 2016;18 (Suupl 2):1-103. (In Russ.)].

11. Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50. doi: 10.1093/cid/civ933.

12. Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015;132(15):1435-86. doi: 10.1161/CIR. 0000000000000296

13. Koehler P, Tacke D, Cornely OA. Aspergillosis of bones and joints – a review from 2002 until today. Mycoses. 2014 Jun; 57(6):323-35. doi: 10.1111/myc.12165. Epub 2014 Jan 8.

14. Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1-e60. doi: 10.1093/cid/ciw326

15. Taroumian S, Knowles SL, Lisse JR, et al. Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs. Arthritis Care Res (Hoboken). 2012;64(12): 1903-9. doi: 10.1002/acr.21784.

16. Galgiani JN, Ampel NM, Blair JE. 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112-46. doi: 10.1093/cid/ciw360

17. Olson TC, Bongartz T, Crowson CS, et al. Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009. BMC Infect Dis. 2011 May 23;11:145. doi: 10.1186/1471- 2334-11-145.

18. Vergidis P, Avery RK, Wheat LJ. Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015;61(3):409-17. doi: 10.1093/cid/civ299

19. Riddell J, Kauffman CA, Smith JA, et al. Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment. Medicine (Baltimore). 2014;93(5):186-93. doi: 10.1097/ MD.0000000000000034

20. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc. 2008;83(2):181-94.

21. Liao TL, Chen YM, Chen DY. Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications. Clin Microbiol Infect. 2016;22(9):815. e1-815.e3. doi: 10.1016/j.cmi.2016.05.030

22. Falagas ME, Manta KG, Betsi GI, Pappas G. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol. 2007;26(5):663-70. doi: 10.1007/ s10067-006-0441-9

23. Hugle B, Solomon M, Harvey E, et al. Pneumocystis jirovecii pneumonia following Rituximab treatment in Wegener's Granulomatosis. Arthritis Care Res (Hoboken). 2010 Nov;62(11):1661-4. doi: 10.1002/acr.20279. Epub 2010 Jun 25.

24. Teichmann LL, Woenckhaus M, Vogel C, et al. Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology (Oxford). 2008;47(8): 1256-7. doi: 10.1093/rheumatology/ken234

25. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum. 1999;42(4):780-9.

26. Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis. 2002;34(8):1098-107.

27. Gerrard JG. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust. 1995;162(5):233-5.

28. Stamp LK, Hurst M. Is there a role for consensus guidelines for P. jiroveci pneumonia prophylaxis in immunosuppressed patients with rheumatic diseases? J Rheumatol. 2010;37(4):686-8. doi: 10.3899/ jrheum.091426.

29. Grubbs JA, Baddley JW. Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis. Curr Rheumatol Rep. 2014;16(10):445. doi: 10.1007/s11926-014-0445-4

30. Appenzeller S, Amaral TN, Amstalden EM, et al. Sporothrix schenckii infection presented as monoarthritis: report of two cases and review of the literature. Clin Rheumatol. 2006;25(6):926-8.

31. Васильева НВ, Климко НН, Цинзерлинг ВА. Диагностика и лечение инвазивных микозов: современные рекомендации. Вестник СПб МАПО. 2010;2(4):5-18. [Vasil'eva NV, Klimko NN, Tsinzerling VA. Diagnosis and treatment of invasive fungal infections: current recommendations. Vestnik SPb MAPO. 2010;2(4):5-18. (In Russ.)].


Для цитирования:


Белов Б.С., Тарасова Г.М., Буханова Д.В. Микотические инфекции в ревматологии. Современная ревматология. 2017;11(2):18-24. https://doi.org/10.14412/1996-7012-2017-2-18-24

For citation:


Belov B.S., Tarasova G.M., Bukhanova D.V. Mycotic infections in rheumatology. Modern Rheumatology Journal. 2017;11(2):18-24. (In Russ.) https://doi.org/10.14412/1996-7012-2017-2-18-24

Просмотров: 485


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)